必赢3003no1线路检测中心

陆军军医大学第一附属医院（重庆西南医院）病理科，主任医师、教授，国家级青年人才

工作经历

2024/12-今，陆军军医大学第一附属医院病理科，教授/主任医师

2019/12-2024/11，陆军军医大学第一附属医院病理科，副教授/副主任医师

2018/10-2019/11，陆军军医大学第一附属医院病理科，副教授/主治医师

2016/10-2018/09，陆军军医大学第一附属医院病理科，博士后

研究方向、教学课程

时雨，陆军军医大学第一附属医院（重庆西南医院）病理科教授、主任医师、博士生导师，国家自然科学基金优秀青年基金和重庆自然科学基金杰出青年基金获得者，国家重点研发计划首席青年科学家，获中国抗癌协会“青年科学家奖”、中华医学会“中国病理研究杰出青年奖”、中国医疗保健国际交流促进会“华夏青年医学科技奖”和重庆市“十佳科技青年奖”。兼任中国抗癌协会青年理事、中国抗癌协会肿瘤转移专业委员会常务委员，中华医学会病理学分会科研工作委员会副组长。

研究方向：主要从事“恶性胶质瘤空间免疫病理及诊疗意义”研究。系统研究肿瘤相关巨噬细胞（TAM）的空间异质性及其对胶质瘤干细胞（GSC）和抗瘤免疫的调控作用。包括：（1）绘制了胶质瘤空间病理图谱，鉴定出TAM新功能亚群，解析了其空间生态位异质性；（2）揭示了胶质瘤关键空间区域（缺氧区、围血管区、侵袭边缘区）内TAM的功能分工，阐明了其诱导免疫抑制、血管重塑和GSC侵袭的具体机制；（3）发展了针对TAM空间生态位的干预及联合治疗新策略。主持国家自然科学基金青年基金B类项目（原优青项目）和联合基金项目、国家重点研发计划青年科学家项目、国家科技重大专项课题在内的国家及省部级课题12项。发表论文60余篇，其中以第一或通讯作者发表SCI论文25篇（IF>20 论文7篇，IF>10论文8篇），他引5500余次，H指数39。担任SCI杂志Modern Pathology、Laboratory Investigation、MedComm、Genes & Diseases编委。授权国家发明专利11件。曾入选国家博士后创新人才支持计划。

教学课程：作为重庆市高校一流本科课程（病理学）团队骨干，承担本科和研究生病理学和肿瘤学的理论、实训和前沿进展课程，授课1000余课时，深受学生欢迎，评为陆军军医大学“教学标兵”。坚持基础与临床相结合，启发学生科研创新能力，指导学生获得“全国大学生医学创新大赛金奖（2023、2024、2025）”和“全国高等医药院校大学生形态学绘图大赛一等奖（2024）和二等奖（2023）”。加强肿瘤病理学建设和发展，作为导师/导师组成员培养硕士研究生11名和博士研究生8名，被评为“重庆市青年专家工作室领衔专家（2022）”和“重庆市学术技术带头人后备人才（2024）”。

科研成果：

一、以通讯(＊)/第一作者( ^# )(含共同)发表SCI收录论文25篇

(1) Wenying Wang^#, Tianran Li^#, Yue Cheng^#, Fei Li^#, Shuhong Qi^#, Min Mao, Jingjing Wu, Qing Liu, Xiaoning Zhang, Xuegang Li, Lu Zhang, Haoyue Qi, Lan Yang, Kaidi Yang, Zhicheng He, Shuaishuai Ding, Zhongyi Qin, Ying Yang, Xi Yang, Chunhua Luo, Ying Guo, Chao Wang, Xindong Liu, Lei Zhou, Yuqi Liu, Weikai Kong, Jingya Miao, Shuanghui Ye, Min Luo, Lele An, Lujing Wang, Linrong Che, Qin Niu, Qinghua Ma, Xia Zhang, Zhihong Zhang, Rong Hu, Hua Feng, Yi-Fang Ping^*, Xiu-Wu Bian^*, Yu Shi^*. Identification of Hypoxic Macrophages in Glioblastoma with Therapeutic Potential for Vasculature Normalization. Cancer Cell 2024, 42: 815-832 (IF=44.5).

(2) Yue Cheng^#, Tianran Li^#, Mengru Wang^#, Chuan Lan^#, Haizhen Fan, Zhicheng He, Qing Liu, Fei Li, Lujing Wang, Wenying Wang, Gehao Chen, Tunan Chen, Min Mao, Qianying Ruan, Lixia Wang, Xiaoning Zhang, Haoyue Qi, Yi Zhang, Xinyue Zhou, Jiayu Duan, Chunhua Luo, Chao Wang, Shuanghui Ye, Weikai Kong, Haitao Guo, Qin Niu, Zhen Qin, Qing Yan, Qinghua Ma, Xia Zhang, Rong Hu, Hua Feng, Yi-Fang Ping, Xiu-Wu Bian^*, Yu Shi^*. Pharmacological activation of WASp potentiates macrophage phagocytosis and enhances ibrutinib efficacy against mouse models of brain tumors. Science Translational Medicine 2026;18(844):eaed1155 (IF=14.6).

(3) Yifan Zhao^#, Yanfeng Dai^#,*, Xiang Yu, Wenying Wang, Gehao Chen, Yi Liu, Xuenan Yuan, Mianfu Cao, Juan Chen, Yu Shi^*, Zhihong Zhang^*. Adrenomedullin Antagonist Nanoparticles Inhibit Breast Cancer Brain Metastasis by Immunomodulating Monocytes/Macrophages. ACS Nano 2026;20(12):9656-9675 (IF=16.0).

(4) Ying Yang^#, Lujing Wang^#, Yi Zhang^#, Shuzhen Lyu^#, Qianying Ruan^#, Chao Wang, Feiyue Dou, Gongbo Liang, Guangning Yan, Mengru Wang, Haizhen Fan, Haoyue Qi, Weikai Kong, Haitao Guo, Qing Liu, Wenying Wang, Min Mao, Yuxi Huang, Xinyue Zhou, Jiayu Duan, Wangyang Song, Bangguo Huang, Yuhui Cheng, Lei Zhou, Senlin Xu, Jun Shen, Yi-Fang Ping, Xiu-Wu Bian, Zhicheng He*, Yu Shi*. Human induced pluripotent stem cell-derived chimeric antigen receptor-macrophages eradicate IL-13Rα2-positive solid tumors. The Journal of Pathology, accepted (IF=5.2).

(5) Mengru Wang, Zhen Qin, Xiu-Wu Bian^*, Yu Shi^*. Harnessing chimeric antigen receptor macrophages against solid tumors. Cancer Communications 2025;45(11):1344-1366. (IF=24.9).

(6) Zhen Qin, Xiu-Wu Bian*, Yu Shi^*. Identification of hypoxic macrophages in glioblastoma: Unveiling therapeutic insights from tumour microenvironment analysis. Clinical and Translational Medicine 2024;14(9):e70013 (IF=7.9).

(7) Xudong Xing^#, Jian Zhong^#, Jana Biermann^#, Hao Duan^#, Xinyu Zhang^#, Yu Shi^#, Yixin Gao, Kejun He, Duanyang Zhai, Feng Luo, Yanxing Lai, Feizhe Xiao, Wenying Wang, Mengru Wang, Jianguo Xu, Hao Liu, Jiaze Tang, Liangzhao Chu, Tunan Chen, Edridge K. D’Souza, Lindsay Caprio, Leon Ebel, Devanik Biswas, Azzurra Cottarelli, Yonggao Mou^*, Benjamin Izar^*, Nu Zhang^*, Fan Bai^*. Pan-cancer human brain metastases atlas at single-cell resolution. Cancer Cell 2025, 43, 1242-1260 (IF=44.5).

(8) Jian Zhong^#, Xujia Wu^#, Yixin Gao^#, Junju Chen^#, Maolei Zhang, Huangkai Zhou, Jia Yang, Feizhe Xiao, Xuesong Yang, Nunu Huang, Haoyue Qi, Xiuxing Wang^*, Fan Bai^*, Yu Shi^*, Nu Zhang^*. Circular RNA encoded MET variant promotes glioblastoma tumorigenesis. Nature Communications 2023, 14(1):4467 (IF=16.6).

(9) Jian Zhong^#, Xuesong Yang^#, Junju Chen^#, Kejun He^#, Xinya Gao, Xujia Wu, Maolei Zhang, Huangkai Zhou, Feizhe Xiao, Lele An, Xiuxing Wang^*, Yu Shi^*, Nu Zhang^*. Circular EZH2-encoded EZH2-92aa mediates immune evasion in glioblastoma via inhibition of surface NKG2D ligands. Nature Communications 2022, 13(1):4795 (IF=16.6).

(10) Xiao-Ning Zhang, Kai-Di Yang, Cong Chen, Zhi-Cheng He, Qiang-Hu Wang, Hua Feng, Sheng-Qing Lv, Yan Wang, Min Mao, Qing Liu, Yao-Yao Tan, Wen-Ying Wang, Tian-Ran Li, Lin-Rong Che, Zhong-Yi Qin, Ling-Xiang Wu, Min Luo, Chun-Hua Luo, Yu-Qi Liu, Wen Yin, Chao Wang, Hai-Tao Guo, Qing-Rui Li, Bin Wang, Wei Chen, Shuang Wang, Yu Shi^*, Xiu-Wu Bian^*, Yi-Fang Ping^*. Pericytes augment glioblastoma cell resistance to temozolomide through CCL5-CCR5 paracrine signaling. Cell Research 2021, 31:1072-1087 (IF=46.3).

(11) Chao Wang^#, Yinming Zhong^#, Yi Zhang^#, Yiyang Jiang, Chenshiyu Wang, Lele An, Chunhua Luo, Lan Yang, Zhicheng He, Ying Yang, Min Luo, Min Mao, Wenying Wang, Qing Liu, Yu Shi^*, Yi-Fang Ping^*. Cd248a regulates pericyte development and viability in zebrafish. Communications Biology 2025, 8(1):451 (IF=5.2).

(12)Wen Yin, Yi-Fang Ping, Fei Li, Sheng-Qing Lv, Xiao-Ning Zhang, Xue-Gang Li, Ying Guo, Qing Liu, Tian-Ran Li, Liu-Qing Yang, Kai-Di Yang, Yu-Qi Liu, Chun-Hua Luo, Tao Luo, Wen-Ying Wang, Min Mao, Min Luo, Zhi-Cheng He, Mian-Fu Cao, Cong Chen, Jing-Ya Miao, Hui Zeng, Chao Wang, Lei Zhou, Ying Yang, Xi Yang, Qiang-Hu Wang, Hua Feng, Yu Shi*, Xiu-Wu Bian*. A map of the spatial distribution and tumour-associated macrophage states in glioblastoma and grade-4 IDH-mutant astrocytoma. The Journal of Pathology 2022, 258(2):121-135 (IF=7.3).

(13) Zhi-Cheng He, Qing Liu, Kai-Di Yang, Cong Chen, Xiao-Ning Zhang, Wen-Ying Wang, Hui Zeng, Bin Wang, Yu-Qi Liu, Min Luo, Lei Li, Qin Niu, Hui-Min Lu, Tao Luo, Xiao-Hong Yao, Hai-Tao Guo, Jia-Le Ji, Mian-Fu Cao, Yu Shi^*, Yi-Fang Ping^*, Xiu-Wu Bian^*. HOXA5 is amplified in glioblastoma stem cells and promotes tumor progression by transcriptionally activating PTPRZ1. Cancer Letters 2022, 533, 215605 (IF=9.7).

(14) Min Luo^#, Yu-Qi Liu^#, Hua Zhang, Chun-Hua Luo, Qing Liu, Wen-Ying Wang, Zhi-Cheng He, Cong Chen, Xiao-Ning Zhang, Min Mao, Kai-Di Yang, Chao Wang, Xiao-Qing Chen, Wen-Juan Fu, Qin Niu, Xiu-Wu Bian, Yu Shi^*, Yi-Fang Ping^*. Overexpression of carnitine palmitoyltransferase 1A promotes mitochondrial fusion and differentiation of glioblastoma stem cells. Laboratory Investigation 2022, 102(7):722-730 (IF=5.6).

(15) Kai Zhou, Jun Rao, Zhihua Zhou, Xiaohong Yao, Feng Wu, Jing Yang, Lang Yang, Xia Zhang, Youhong Cui, Xiu-Wu Bian ^*, Yu Shi^*, Yifang Ping^*. RAC1-GTP promotes epithelial-mesenchymal transition and invasion of colorectal cancer by activation of STAT3. Laboratory Investigation 2018, 98(8):989-998 (IF=3.7).

(16) Kai Zhou, Yue-Liang Yao, Zhi-Cheng He, Cong Chen, Xiao-Ning Zhang, Kai-Di Yang, Yu-Qi Liu, Qing Liu, Wen-Juan Fu, Ya-Ping Chen, Qin Niu, Qing-Hua Ma, Rong Zhou, Xiao-Hong Yao, Xia Zhang, You-Hong Cui, Xiu-Wu Bian^*, Yu Shi^*, Yi-Fang Ping^*. VDAC2 interacts with PFKP to regulate glucose metabolism and phenotypic reprogramming of glioma stem cells. Cell Death & Disease 2018, 9(10):988 (IF=8.5).

(17) Han Chua^#, Yu Shi^#, Zhi-Gang Tian, Jun Ma, Xiu-Wu Bian^*, Bo Zhu^*. Spatial Omics Revisits Cancer Immunity and Reshapes Immunotherapy. Fundamental Research, accepted (IF=6.3).

(18) Yu Shi, Olga A. Guryanova, Wenchao Zhou, Chong Liu, Zhi Huang, Xiaoguang Fang, Xiuxing Wang, Cong Chen, Qiulian Wu, Zhicheng He, Wei Wang, Wei Zhang, Tao Jiang, Qing Liu, Yaping Chen, Wenying Wang, Jingjing Wu, Leo Kim, Ryan C. Gimple, Hua Feng, Hsiang-Fu Kung, Jennifer S. Yu, Jeremy N. Rich, Yifang Ping^*, Xiu-Wu Bian^*, Shideng Bao^*. Ibrutinib Inactivates BMX-STAT3 in Glioma Stem Cells to Impair Malignant Growth and Radioresistance. Science Translational Medicine 2018, 10(443): eaah6816 (IF=17.9).

(19) Xiao-Hong Yao^#, Tao Luo^#, Yu Shi^#, Zhi-Cheng He^#, Rui Tang^#, Pei-Pei Zhang ^#, Jun Cai, Xiang-Dong Zhou, Dong-Po Jiang, Xiao-Chun Fei, Xue-Quan Huang, Lei Zhao, Heng Zhang, Hai-Bo Wu, Yong Ren, Zhen-Hua Liu, Hua-Rong Zhang, Cong Chen, Wen-Juan Fu, Heng Li, Xin-Yi Xia, Rong Chen, Yan Wang, Xin-Dong Liu, Chang-Lin Yin, Ze-Xuan Yan, Juan Wang, Rui Jing, Tai-Sheng Li, Wei-Qin Li, Chao-Fu Wang, Yan-Qing Ding, Qing Mao, Ding-Yu Zhang, Shu-Yang Zhang*, Yi-Fang Ping*, Xiu-Wu Bian*. A cohort autopsy study defines COVID-19 systemic pathogenesis. Cell Research 2021, 31(8):836-846 (IF=46.3).

(20) Qian Liu^#, Yu Shi^#, Jun Cai^#, Yaqi Duan^#, Rongshuai Wang^#, Hongyan Zhang^#, Qiurong Ruan^#, Jiansha Li^#, Lei Zhao^#, Yifang Ping^#, Rong Chen^#, Liang Ren^#, Xiaochun Fei, Heng Zhang, Rui Tang, Xi Wang, Tao Luo, Xindong Liu, Xuequan Huang, Zhenhua Liu, Qilin Ao, Yong Ren, Jing Xiong, Zhicheng He, Haibo Wu, Wenjuan Fu, Pengnan Zhao, Xinwei Chen, Guoqiang Qu, Yunyun Wang, Xi Wang, Jia Liu, Dongfang Xiang, Sanpeng Xu, Xiaowei Zhou, Qingrui Li, Jinghong Ma, Heng Li, Jie Zhang, Sizhe Huang, Xiaohong Yao*, Yiwu Zhou*, Chaofu Wang*, Dingyu Zhang*, Guoping Wang*, Liang Liu*, Xiu-Wu Bian*. Pathological Changes in the Lungs and Lymphatic Organs of 12 COVID-19 Autopsy Cases. National Science Review 2020, 7(12): 1868-1878 (IF=17.3).

(21) Yu Shi, Yi-Fang Ping, Wenchao Zhou, Zhi-Cheng He, Cong Chen, Bai-Shi-Jiao Bian, Lin Zhang, Lu Chen, Xun Lan, Xian-Chao Zhang, Kai Zhou, Qing Liu, Hua Long, Ti-Wei Fu, Xiao-Ning Zhang, Mian-Fu Cao, Zhi Huang, Xiaoguang Fang, Xiuxing Wang, Hua Feng, Xiao-Hong Yao, Shi-Cang Yu, You-Hong Cui, Xia Zhang, Jeremy N. Rich, Shideng Bao^*, Xiu-Wu Bian^*. Tumour-associated Macrophages Secrete Pleiotrophin to Promote PTPRZ1 Signalling in Glioblastoma Stem Cells for Tumour Growth. Nature Communications 2017, 8:15080 (IF=14.9).

(22) Yu Shi, Yifang Ping, Xia Zhang, Xiuwu Bian^*. Hostile takeover: glioma stem cells recruit TAMs to support tumor progression. Cell Stem Cell 2015, 16(3):219-220 (IF=22.4).

(23) Si Wang^#, Xiaohong Yao^#, Shuai Ma^#, Yifang Ping^#, Yanling Fan^#, Shuhui Sun^#, Zhicheng He^#, Yu Shi^#, Liang Sun^#, Shiqi Xiao^#, Moshi Song^#, Jun Cai, Jiaming Li, Rui Tang, Liyun Zhao, Chaofu Wang, Qiaoran Wang, Lei Zhao, Huifang Hu, Xindong Liu, Guoqiang Sun, Lu Chen, Guoqing Pan, Huaiyong Chen, Qingrui Li, Peipei Zhang, Yuanyuan Xu, Huyi Feng, Guo-Guang Zhao, Tianzi Wen, Yungui Yang, Xuequan Huang, Wei Li, Zhenhua Liu, Hongmei Wang, Haibo Wu, Baoyang Hu, Yong Ren, Qi Zhou^*, Jing Qu^*, Weiqi Zhang^*, Guang-Hui Liu^*, Xiu-Wu Bian^*. A single-cell transcriptomic landscape of the lungs of patients with COVID-19. Nature Cell Biology 2021, 23(12): 1314-1328 (IF=28.8).

(24) Yu Shi, Wenchao Zhou, Lin Cheng, Cong Chen, Zhi Huang, Xiaoguang Fang, Qiulian Wu, Zhicheng He, Senlin Xu, Justin Lathia, Yifang Ping, Jeremy Rich, Xiu-Wu Bian^*, Shideng Bao^*. Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells. Cell Death & Differentiation 2017, 24(1): 167-180 (IF=15.8).

(25) Yu Shi^#, Cong Chen^#, Shizhu Yu, Qing Liu, Jun Rao, Huarong Zhang, Hualiang Xiao, Tiwei Fu, Hua Long, Zhicheng He, Kai Zhou, Xiahong Yao, Youhong Cui, Xia Zhang, Yifang Ping^*, Xiu-Wu Bian^*. miR-663 suppresses oncogenic function of CXCR4 in glioblastoma. Clinical Cancer Research 2015, 21(17): 4004-4013 (IF=8.7).

(26) Yu Shi, Cong Chen, Xia Zhang, Qing Liu, Jinling Xu, Huarong Zhang, Xiaohong Yao, Tao Jiang, Zhicheng He, Yong Ren, Wei Cui, Chuan Xu, Ling Liu, Youhong Cui, Shizhu Yu, Yifang Ping^*, Xiu-Wu Bian^*. Primate specific miR-663 functions as a tumor suppressor by targeting PIK3CD and predicts the prognosis of human glioblastoma. Clinical Cancer Research 2014, 20(7):1803-1813 (IF=8.7).

二、专利

(1) 时雨; 王路静; 杨莹; 刘庆; 张艺; 安乐乐; 抗PTPRZ1嵌合抗原受体巨噬细胞在肺癌治疗中的应用, 授权公告日2025-07-11, 中国, ZL 2024 1 1431010.0.

(2) 时雨; 平轶芳; 刘庆; 杨莹; 安乐乐; 齐皓月; 一种PTN-PTPRZ1通路的阻断抗体及其在胶质瘤靶向治疗的应用, 授权公告日2024-03-26, 中国, ZL20231 1015361.9.

(3) 时雨; 卞修武; 杨莹; 刘庆; 周磊; 安乐乐; 王路静; 抗人PTPRZ1单克隆抗体及其在细胞流式中的应用, 授权公告日2024-03-15, 中国, ZL202310088884.X.

(4) 时雨; 平轶芳; 卞修武; 何志承; 陈聪; 廖嘉明; 靶向干扰肿瘤PTN-PTPRZ1通路的小干扰RNA在肿瘤免疫治疗中的应用, 2019-03-08, 中国, ZL201610980647.4.

(5) 时雨; 王文英；吴晶晶；平轶芳；卞修武; ADM竞争性拮抗剂AMA在胶质瘤免疫治疗中的应用, 2021-05-14, 中国, ZL201910250793.5.

(6) 张晓宁; 易维京; 时雨; 平轶芳; 卞修武; 蔡瑞丽; 廖嘉明; CD146单克隆抗体在胶质瘤血管周细胞检测及分离鉴定中的应用, 2019-03-15, 中国, ZL201611078356.2.

(7) 张晓宁; 时雨; 平轶芳; 谭瑶瑶; 谭玉环; 徐媛媛; 卞修武; 靶向OTUD7B基因的小干扰RNA在胶质瘤靶向治疗中的应用, 2020-09-29, 中国, ZL201910287712.9.

(8) 刘庆; 时雨; 平轶芳; 刘宇奇; 颜泽萱; 卞修武; 脑胶质瘤巨噬细胞类配体的体系构建，授权公告日2023-10-27, 中国, ZL202111187331.7.

(9) 杨凯迪；卞修武；平轶芳；时雨；孔维凯；徐媛媛；钮芹；一种基于核密度函数的量化胶质瘤侵袭性的可视化方法，2020-10-26，中国，ZL 202011157737.6

(10) 罗春花；平轶芳；时雨；卞修武；一种压力和气体可调节的细胞培养装置，授权公告日2022-12-27，中国，CN 218146698 U

(11) 刘宇奇；罗敏；平轶芳；时雨；张志仁；卞修武；敲除Dicer的单核细胞、组合物及其在制备治疗胶质母细胞瘤药物中的应用，授权公告日2024-01-26，中国，CN 115109755 B

三、 目前承担的代表性科研项目6项

(1) 国家重点研发计划干细胞专项青年科学家项目，2021YFA1103000，诱导性多能干细胞（iPSC）源性嵌合抗原受体巨噬细胞（CAR-M）的制备及其在恶性肿瘤免疫治疗中的应用，500万元，2021/12-2026/06，项目负责人。

(2) 癌症、心脑血管、呼吸和代谢性疾病防治研究国家科技重大专项课题，No. 2025ZD0544402，泛癌种血管病理表型诊疗靶点发现和干预策略，420万，2025/10-2029/09，课题负责人。

(3) 国家自然科学基金联合基金项目，U25C2043，多组学解析肺癌脑转移演进调控机制及早期诊断标志物鉴定，207万元，2026/01-2029/12，项目负责人。

(4) 国家自然科学基金面上项目，82373191，胶质母细胞瘤新靶向药依鲁替尼抑制肿瘤相关巨噬细胞吞噬的作用机制研究，48万元，2024/01-2027/12，项目负责人。

(5) 重庆市卫生健康委员会杰出青年后备人才培养专项，HBRC202408，100万元，2024/08-2027/08，项目负责人。

(6) 重庆市自然科学基金杰出青年基金项目，2023NSCQ-JQX0049，胶质瘤血管免疫微环境的细胞互作机制及诊疗意义，100万元，2023/07-2026/06，项目负责人。

四、 代表性奖励和荣誉9项

（1）2025年获中国医疗保健国际交流促进会“华夏青年医学科技奖”

（2）2024年获中国抗癌协会“青年科学家奖”

（3）2024年入选“重庆市学术技术带头人后备人才（基础医学）”

（4）2022年入选“重庆市青年专家工作室”领衔专家

（5）2021年荣获“重庆市十佳科技青年奖”

（6）2017年荣获“中国病理研究杰出青年奖”

（7）2017年博士论文被评为“重庆市优秀博士毕业论文”

（8）2017年博士论文被评为“全军优秀博士毕业论文”

（9）2016年入选国家首批“博士后创新人才支持计划”